MarketCap
Facebook
X
Telegram
MacroGenics Income Statement 2025-2010 | MGNX
Brief overview of revenue and earnings at MacroGenics
The figures are compared over a five-year interval. Revenue reported by MacroGenics was 105 million dollars at the beginning of the period and 150 million dollars at the end. The total change was +42.5%, with a CAGR of approximately 7.3%. Revenue advanced gradually over the five-year period.
The five-year EBITDA result moved by +44.9%: from −$119 million to −$65.7 million. There was no major divergence between EBITDA and revenue. EBITDA margin moved from −113.6% to −43.9%. Higher profitability strengthens the quality of operating growth.
The final result was −$130 million initially and −$74.6 thousand in the final year. The loss reduction is constructive, but the recovery is incomplete.
Financial takeaway
The figures do not all move in the same direction. Key strengths include sales growth, a stronger final result and positive operating leverage. The most visible risks are a low EBITDA margin. Further direction will depend on top-line growth, operating profitability, and net income.
Annual Income Statement MacroGenics
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
149 M | 148 M | 1.28 B | 386 M | 962 M | 1.2 B | 466 M | 468 M | 812 M | 621 M | 640 M | 866 M | 266 M | - | - | - |
Shares |
63.2 M | 62.6 M | 61.9 M | 61.4 M | 59.9 M | 52.4 M | 48.1 M | 40.9 M | 36.1 M | 34.7 M | 31.8 M | 27.4 M | 6.85 M | - | - | - |
Historical Prices |
2.36 | 2.36 | 20.6 | 6.28 | 16.1 | 22.9 | 10.9 | 12.7 | 19 | 20.4 | 31 | 35.1 | 27.4 | - | - | - |
Net Income |
-74.6 K | -67 K | -9.06 K | -120 M | -202 M | -130 M | -152 M | -171 M | -19.6 M | -58.5 M | -20.1 M | -38.3 M | -261 K | 8.36 M | 6.72 M | - |
Revenue |
150 M | 150 M | 58.7 M | 152 M | 77.4 M | 105 M | 64.2 M | 60.1 M | 158 M | 91.9 M | 101 M | 47.8 M | 58 M | 63.8 M | 57.2 M | - |
Cost of Revenue |
- | 847 K | 619 K | 3.35 M | 2.65 M | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-72.8 M | -111 M | -168 M | -121 M | -203 M | -131 M | -177 M | -171 M | -22.1 M | -60 M | -20.2 M | -38.3 M | 366 K | 8.2 M | 5.25 M | - |
Interest Expense |
6.06 M | 1.12 M | 1.43 M | 1.66 M | 680 K | 1.32 M | 25.4 M | -247 K | 2.52 M | 1.51 M | 42 K | 2 K | -627 K | 157 K | 1.47 M | - |
EBITDA |
-65.7 M | -103 M | -159 M | -110 M | -192 M | -119 M | -166 M | -163 M | -14.9 M | -52.4 M | -17.3 M | -36.5 M | 1.56 M | 9.17 M | 6.4 M | - |
Operating Expenses |
- | - | - | - | - | - | 241 M | 231 M | 180 M | 152 M | 121 M | 86.1 M | 57.7 M | - | - | - |
General and Administrative Expenses |
39.2 M | 71 M | 52.2 M | 58.9 M | 63 M | 42.7 M | 46.1 M | 40.5 M | 32.7 M | 29.8 M | 22.8 M | 15.9 M | 11.1 M | 10.2 M | 10.9 M | - |
All numbers in USD currency
Quarterly Income Statement MacroGenics
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
63.4 M | 63.2 M | 63.1 M | 63 M | 62.8 M | 62.7 M | 62.7 M | 62.3 M | 62.1 M | 62 M | 61.9 M | 61.8 M | 61.7 M | 61.5 M | 61.4 M | 61.3 M | 61.3 M | 61.2 M | 60.1 M | 57.2 M | 56.2 M | 54.5 M | 50 M | 49 M | 49 M | 48.9 M | 48.8 M | 45.6 M | 42.4 M | 42.2 M | 42.2 M | 36.9 M | 36.9 M | 36.8 M | 35.8 M | 35 M | 34.9 M | 34.8 M | 34.6 M | 34.5 M | 34.3 M | 33.3 M | 30.1 M | 29.4 M | 28 M | 27.8 M | 27.7 M | 26.3 M | 25.2 M | 1.18 M | 1.22 M | 1.15 M | 1.1 M | 1.09 M | - | - | - | - | - | - |
Net Income |
-36.8 M | 16.8 M | -36.3 M | -41 M | - | 56.3 M | -55.7 M | -52.2 M | - | 17.6 M | 57.5 M | -38 M | - | -24.8 M | -41.3 M | -66.4 M | - | -52.9 M | -39.9 M | -51.3 M | - | -36 M | -46.9 M | -44.7 M | -30.4 M | -44.6 M | -31.8 M | -45 M | -44.6 M | -34 M | -43.2 M | -49.5 M | 106 M | -47 M | -40.7 M | -37.7 M | -34.8 M | -33.8 M | 40.5 M | -30.4 M | -28.5 M | -15.4 M | -21.4 M | 45.1 M | -19 M | -3.93 M | -12.3 M | -3.11 M | -3.2 M | 6.6 M | -294 K | -3.37 M | -2.1 M | 2.6 M | 3.55 M | 4.32 M | - | - | - | - |
Revenue |
20.8 M | 72.8 M | 22.2 M | 13.2 M | - | 111 M | 10.8 M | 9.1 M | - | 10.4 M | 13.1 M | 24.5 M | - | 41.7 M | 26 M | 11.1 M | - | 15.7 M | 30.8 M | 16.9 M | - | 18.3 M | 20.3 M | 13.7 M | 25.2 M | 18.7 M | 10.6 M | 9.66 M | 15.8 M | 20.8 M | 18.8 M | 4.7 M | 152 M | 1.66 M | 1.67 M | 2.06 M | 5.11 M | 3.26 M | 80.7 M | 2.85 M | 8.18 M | 14.7 M | 6.72 M | 71.3 M | 5.48 M | 18.4 M | 9.22 M | 14.7 M | 14.9 M | 20.2 M | 12.3 M | 10.6 M | 9.8 M | 16.1 M | 17.4 M | 20.5 M | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | 168 K | 176 K | 270 K | - | 85 K | 258 K | 113 K | - | 3.01 M | 180 K | 48 K | - | 1.66 M | 22 K | 17 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-33.4 M | 18.6 M | -36.8 M | -42.6 M | - | 54.2 M | -58.2 M | -53.8 M | - | -35.5 M | -45 M | -38.4 M | - | -25 M | -41.8 M | -66.6 M | - | -53 M | -40.3 M | -51.3 M | - | -36.1 M | -47.3 M | -45.4 M | - | -37.9 M | -53 M | -47.6 M | - | -35 M | -44.3 M | -50.2 M | - | -47.7 M | -41.2 M | -38.2 M | - | -34.3 M | 40.1 M | -30.6 M | - | -15.4 M | -21.3 M | 45.1 M | - | -3.93 M | -12.3 M | -3.11 M | - | 7.16 M | -254 K | -3.33 M | - | 2.6 M | - | - | - | - | - | - |
Interest Expense |
4.89 M | 3.34 M | 802 K | 91 K | - | - | 6 K | 1.13 M | - | - | 774 K | - | - | 142 K | 504 K | 195 K | - | 101 K | 344 K | 21 K | - | 92 K | 425 K | 721 K | - | -6.69 M | 21.2 M | 2.6 M | - | 975 K | 1.07 M | 674 K | - | 681 K | 525 K | 553 K | - | 419 K | 370 K | 270 K | - | 1 K | -86 K | -3 K | - | - | 1 K | - | - | -554 K | -40 K | -34.2 K | - | 1.56 K | - | - | - | - | - | - |
EBITDA |
-31.8 M | - | - | -40.9 M | - | - | - | -51.9 M | - | - | - | -35.4 M | - | -16.3 M | -36 M | -63.7 M | - | -44.7 M | -34.8 M | -48.6 M | - | -27.1 M | -41.2 M | -42.4 M | - | -28.7 M | -46.8 M | -44.7 M | - | -29.7 M | -41.8 M | -48.9 M | - | -41.8 M | -37.2 M | -36.2 M | - | -28.6 M | 43.7 M | -28.9 M | - | -13.8 M | -20.1 M | 45.7 M | - | -2.61 M | -11.4 M | -2.71 M | - | 7.47 M | 264 K | -3.08 M | - | 2.83 M | - | - | - | - | - | - |
General and Administrative Expenses |
9.71 M | 9.9 M | 9.3 M | 10.7 M | - | 14.1 M | 14.4 M | 14.7 M | - | 12.4 M | 13.7 M | 13.5 M | - | 15.4 M | 13.7 M | 16.3 M | - | 17.2 M | 15.2 M | 15 M | - | 9.73 M | 10.2 M | 10.2 M | - | 11.8 M | 12.1 M | 10.2 M | - | 9.58 M | 11.1 M | 9.24 M | - | 8.4 M | 8.38 M | 7.46 M | - | 7.22 M | 7.24 M | 6.13 M | - | 6.02 M | 5.35 M | 4.68 M | - | 3.68 M | 4.14 M | 3.26 M | - | 1.99 M | 1.5 M | 3.83 M | - | 1.51 M | - | - | - | - | - | - |
All numbers in USD currency
The income statement is one of the three key financial reports of a company MacroGenics (alongside the balance sheet and the cash flow statement). It shows how the company makes money and what its expenses are:
- How much revenue the company earned
- How much it spent on production, personnel, marketing, taxes, etc.
- What profit remained in the end
Analyzing the income statement helps an investor understand whether the business generates stable and growing profits, how effectively the company controls its expenses, and whether it is capable of generating income in the future. Additionally, this analysis shows how the company copes with crises and economic cycles, and allows assessing the potential for stock price growth and dividend payments.
Features- The income statement may include both recurring and one-time items (for example, profit from the sale of assets). It is necessary to separate core metrics from one-off events for accurate analysis.
- Companies often publish interim reports (e.g., quarterly), which allows for more timely tracking of trends.
- A combined analysis of the income statement with the balance sheet and cash flow statement provides a comprehensive view of the company’s financial health.
USA
Canada
China
France
Germany
Israel
Britain
Russia
Belgium
Cayman-islands